TNF and inflammatory bowel disease: The evolution of knowledge on the involvement of certain cytokines, notably tumour necrosis factor (TNF)-α in the immunopathogenesis of inflammatory bowel disease (IBD) has stimulated the development of anti-TNF antibodies as novel biologics for the treatment of IBD [1–3].